|
18 Companies |
|
31 Products |
|
31 Products |
|
32 Mechanisms of Action |
|
1 Trial |
|
87 News |
|
| «12 |
- | valacyclovir / Generic mfg.
Trial completion: Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed
- | Zarnestra (tipifarnib) / Kura Oncology, Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Trial completion: Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia (clinicaltrials.gov) - Feb 22, 2014
P2, N=100, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | melphalan / Generic mfg., busulfan / Generic mfg.
Trial completion: Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease (clinicaltrials.gov) - Feb 19, 2014
P2, N=390, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | thioguanine / Generic mfg.
Trial completion: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome (clinicaltrials.gov) - Feb 19, 2014
P3, N=254, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- fludarabine IV / Generic mfg., mycophenolate mofetil / Generic mfg.
Enrollment open, IO biomarker: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (clinicaltrials.gov) - Dec 19, 2013
P1, N=20, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
No longer recruiting --> Completed Active, not recruiting --> Recruiting
- | Enbrel (etanercept) / Pfizer, Amgen
Clinical: Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant (clinicaltrials.gov) - Oct 21, 2013
P2, N=39, Active, not recruiting, Sponsor: Children's Oncology Group
Active, not recruiting --> Recruiting Completed --> Active, not recruiting
- MK-2206 / Merck (MSD)
Trial completion: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (clinicaltrials.gov) - Sep 26, 2013
P1, N=45, Completed, Sponsor: National Cancer Institute (NCI)
Completed --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies (clinicaltrials.gov) - Jul 14, 2013
P1, N=48, Completed, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Enrollment open: Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia (clinicaltrials.gov) - Jul 1, 2013
P2, N=145, Recruiting, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change, HEOR: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (clinicaltrials.gov) - Jun 25, 2013
P=N/A, N=80, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Not yet recruiting --> Recruiting N=64 --> 80
- ||||| thioguanine / Generic mfg.
Enrollment change: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome (clinicaltrials.gov) - Jun 25, 2013
P3, N=254, Completed, Sponsor: Children's Oncology Group
N=64 --> 80 N=158 --> 254
- Trial completion: Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy (clinicaltrials.gov) - Jun 9, 2013
P1, N=20, Completed, Sponsor: University of Louisville
N=158 --> 254 Recruiting --> Completed
- Kepivance (palifermin) / SOBI, Amgen
Enrollment change: Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant (clinicaltrials.gov) - May 29, 2013
P2, N=0, Withdrawn, Sponsor: Children's Oncology Group
Recruiting --> Completed N=200 --> 0
- Trial termination: Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant (clinicaltrials.gov) - May 10, 2013
P1, N=252, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
N=200 --> 0 Completed --> Terminated; study closed prematurely upon PI's departure from VICC
- Trial completion, HEOR: Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer (clinicaltrials.gov) - Apr 28, 2013
P2, N=750, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Completed --> Terminated; study closed prematurely upon PI's departure from VICC Active, not recruiting --> Completed
- ||||| New P2 trial: Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia (clinicaltrials.gov) - Apr 3, 2013
P2, N=145, Recruiting, Sponsor: Children's Oncology Group
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Clinical: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (clinicaltrials.gov) - Feb 27, 2013
P2, N=47, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment change: S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=3341, Completed, Sponsor: Southwest Oncology Group
Recruiting --> Active, not recruiting N=2500 --> 3341
- Trial completion: S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=3341, Completed, Sponsor: Southwest Oncology Group
N=2500 --> 3341 Active, not recruiting --> Completed
- Trial completion: S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=1294, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=244, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed N=386 --> 244
- Trial completion: Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant (clinicaltrials.gov) - Nov 28, 2012
P=N/A, N=244, Completed, Sponsor: Fred Hutchinson Cancer Research Center
N=386 --> 244 Active, not recruiting --> Completed
- Enrollment change: Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer (clinicaltrials.gov) - Nov 20, 2012
P2, N=10, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed N=30 --> 10
- peripheral blood stem cell transplantation / National Cancer Institute
Trial completion: Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease (clinicaltrials.gov) - Nov 7, 2012
P1, N=21, Completed, Sponsor: University of California, San Francisco
N=30 --> 10 Recruiting --> Completed
- Enrollment closed: A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies (clinicaltrials.gov) - Oct 15, 2012
P2, N=50, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Completed Recruiting --> Active, not recruiting
- Neupogen (filgrastim) / Kyowa Kirin, Amgen
Clinical: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Oct 8, 2012
P=N/A, N=43, Terminated, Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting --> Active, not recruiting N=60 --> 43
- Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial termination: Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer (clinicaltrials.gov) - Sep 11, 2012
P=N/A, N=8, Terminated, Sponsor: University of California, San Francisco
N=60 --> 43 Completed --> Terminated; lack of efficacy
- Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment change: Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer (clinicaltrials.gov) - Sep 11, 2012
P=N/A, N=8, Terminated, Sponsor: University of California, San Francisco
Completed --> Terminated; lack of efficacy N=10 --> 8
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Enrollment open: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant (clinicaltrials.gov) - Aug 20, 2012
P2, N=39, Recruiting, Sponsor: St. Jude Children's Research Hospital
N=10 --> 8 Not yet recruiting --> Recruiting
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
New P2 trial: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant (clinicaltrials.gov) - Jun 14, 2012
P2, N=39, Recruiting, Sponsor: St. Jude Children's Research Hospital
- Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment closed: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant (clinicaltrials.gov) - Mar 30, 2012
P2, N=88, Active, not recruiting, Sponsor: Cancer and Leukemia Group B
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment closed, HEOR: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer (clinicaltrials.gov) - Mar 21, 2012
P=N/A, N=80, Active, not recruiting, Sponsor: Comprehensive Cancer Center of Wake Forest University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Enrollment change: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (clinicaltrials.gov) - Feb 21, 2012
P2, N=32, Completed, Sponsor: City of Hope Medical Center
Recruiting --> Active, not recruiting N=60 --> 32
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Trial completion: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (clinicaltrials.gov) - Feb 21, 2012
P2, N=32, Completed, Sponsor: City of Hope Medical Center
N=60 --> 32 Active, not recruiting --> Completed
- Trial completion: Non-Ablative Allo HSCT For Hematologic Malignancies or SAA (clinicaltrials.gov) - Oct 12, 2011
P2, N=58, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Oct 4, 2011
P2, N=34, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed